دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش: 1 نویسندگان: Séndor Eckhardt (auth.), Toshio Takahashi M.D. (eds.) سری: ISBN (شابک) : 9784431682547, 9784431682523 ناشر: Springer Tokyo سال نشر: 1993 تعداد صفحات: 888 زبان: English فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) حجم فایل: 39 مگابایت
کلمات کلیدی مربوط به کتاب پیشرفت های اخیر در مدیریت سرطان های گوارشی: مقالات کنفرانس UICC کیوتو بین المللی پیشرفت های اخیر در مدیریت سرطان های گوارشی، 31 مارس و 2 آوریل 1993: انکولوژی
در صورت تبدیل فایل کتاب Recent Advances in Management of Digestive Cancers: Proceedings of UICC Kyoto International Symposium on Recent Advances in Management of Digestive Cancers, March 31–April 2, 1993 به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب پیشرفت های اخیر در مدیریت سرطان های گوارشی: مقالات کنفرانس UICC کیوتو بین المللی پیشرفت های اخیر در مدیریت سرطان های گوارشی، 31 مارس و 2 آوریل 1993 نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
سرطان عامل اصلی مرگ و میر در بسیاری از کشورها است و سرطان دستگاه گوارش یکی از شایع ترین انواع نئوپلاسم است. بنابراین پیشرفت در تحقیقات در مورد مدیریت سرطان گوارش نشان دهنده کمک مهمی به رفاه نوع بشر در سراسر جهان است. سمپوزیوم بین المللی VICC Kyoto در زمینه پیشرفت های اخیر در مدیریت سرطان گوارش در کیوتو از 31 مارس تا 2 آوریل 1993 به ریاست دکتر T. Takahashi از دانشگاه پزشکی استان کیوتو برگزار شد. در این رویداد، محققان و پزشکان برجسته یافته های جدید و آخرین نتایج آزمایشات بالینی در مورد سرطان های گوارشی را ارائه کردند. رئیس VICC و سایر اعضای کمیته اجرایی VICC نیز در زمینه های خود سخنرانی کردند و بیش از 1000 شرکت کننده از 28 کشور با استقبال بسیار خوبی روبرو شدند. این کتاب مجموعه مقالات این سمپوزیوم را ارائه می کند. علاوه بر 30 مقاله برگزیده ارائه شده در سخنرانی ها و سمپوزیوم های ویژه توسط سخنرانان دعوت شده، این کتاب حاوی 230 مقاله رایگان است که در جلسات پوستر در این کنفرانس ارائه شده است.
Cancer is the leading cause of death in many countries, and digestive cancer is one of the most common types of neoplasms. Advances in research on the management of digestive cancer therefore represent an important contribution to the welfare of humankind throughout the world. The VICC Kyoto International Symposium on Recent Advances in the Management of Digestive Cancer was held in Kyoto from March 31 to April 2, 1993 under the presidency of Dr. T. Takahashi of the Kyoto Prefectural Vniversity of Medicine. At this event, leading researchers and clinicians presented new findings and the latest results of clinical trials concerning digestive cancers. The VICC President and other members of the Executive Committee of the VICC also gave speeches on their own fields, and more than 1000 participants from 28 countries were very well received. This book presents the proceedings of this symposium. In addition to 30 selected papers presented at special lectures and symposia by invited speakers, this book contains 230 free papers presented at poster sessions during this conference.
Front Matter....Pages I-XXXI
Front Matter....Pages 1-1
The Role of UICC in the Management of Cancer Patients....Pages 2-6
Mechanisms for Organ Specific Metastasis, in Particular from the Gastro-Intestinal Tract to the Liver....Pages 7-12
Front Matter....Pages 13-13
Present and Prospective Trends of Digestive Cancer in Germany....Pages 14-18
Present and Prospective Trends of Digestive Cancers in Korea....Pages 19-23
Rise and Fall in Environmental Cancer Mortality and Suggestion to Prevention Programs....Pages 24-28
Present and Prospective Trends of Digestive Cancers in the World (USA)....Pages 29-35
Front Matter....Pages 37-37
Prevention of Digestive Cancers — The UICC Project on Evaluation of Primary Prevention....Pages 38-45
The Role of Nutrition in the Cause and Prevention of Digestive Cancers....Pages 46-50
Epidemiology of Stomach Cancer in Japan with Special Reference to the Relationship Between Atrophic Gastritis and Stomach Cancer....Pages 51-55
Pathogen Oriented Prevention of Hepatocellular Carcinoma in Japan....Pages 56-61
Front Matter....Pages 63-63
Recent Advances in the Diagnosis and Treatment of Superficial Esophageal Cancer....Pages 64-66
Recent Advances in Early Detection and Treatment of Gastric Cancer....Pages 67-69
Early Detection of Colorectal Cancer and Advancement in Its Treatment in Japan....Pages 70-75
Long-Term Results of a German Prospective Multicenter Study on Colo-Rectal Cancer....Pages 76-80
Evaluation of Early Detection and Treatment of Hepatocellular Carcinoma....Pages 81-86
Recent Advances in Diagnosis and Surgical Treatment of Pancreatic Cancer....Pages 87-91
Front Matter....Pages 93-93
Endoscopic Mucosal Resection for Early Carcinomas of the Esophagus....Pages 94-97
Endoscopic Surgery for Gastric Cancer....Pages 98-103
Radio-Immunoguided Surgery for Large Bowel Cancer....Pages 104-108
Computer Assisted Surgery for Gastric Cancer....Pages 109-114
Front Matter....Pages 93-93
Targeting Chemotherapy for Digestive Cancer Using Monoclonal Antibody Drug Conjugate....Pages 115-120
Hepatocellular Carcinoma: Hepatic Resection Versus Transplantation....Pages 121-124
Inhibition of Vascularization in Cancer....Pages 125-130
Front Matter....Pages 131-131
Evaluation of Efficacy of Chemotherapy/Radiation Therapy in The Treatment of Inoperative Gastric Cancer with Primary Foci....Pages 132-137
Angiotensin II Induced Hypertension Chemotherapy (IHC) for Advanced Gastric Carcinoma....Pages 138-142
Prerequisites of Adjuvant and Neoadjuvant Chemotherapy in Gastric Cancer....Pages 143-147
Adjuvant Therapy of Gastric Cancer in the West....Pages 148-153
Immunochemosurgery for Advanced Gastric Cancer....Pages 154-159
Experimental and Clinical Results of Hyperthermo-Chemo-Radiotherapy in Esophageal and Rectal Carcinoma....Pages 160-165
Front Matter....Pages 167-167
Immunohistological Evaluation of the Presence of Keratins in Esophageal Cancer....Pages 168-170
Immunohistochemical Evaluation of E-Cadherin and α-Catenin Expression in Human Esophageal Cancer....Pages 171-173
A Spectrophotometric Study of DNA Ploidy Patterns of Esophageal Squamous Cell Carcinoma....Pages 174-176
Experimental Radioimmunodetection for Esophageal Carcinoma by Monoclonal Antibody KIS-1 Fragment....Pages 177-178
Synergistic Antitumoral Effects of Δ 12 -Prostaglandin J 2 and Recombinant Human TNF-α on Human Esophageal Cancer Cell Lines....Pages 179-181
Esophageal Carcinoma — An Analyses of 502 Cases....Pages 182-184
Clinical Study of Superficial Esophageal Carcinoma....Pages 185-187
Clinical Results of Transhiatal Esophagectomy for Carcinoma of the Lower Esophagus....Pages 188-190
Esophagectomy in Geriatric Patients....Pages 191-193
Clinicopathological Evaluation of the Three-Field Lymph Node Dissection for Thoracic Esophageal Cancer....Pages 194-196
Front Matter....Pages 197-199
The Surgical Significance of Proper Nodes Along the Right Laryngeal Nerve Chain Situated in the Supreme Portion of the Thorax, Designated as “Top Nodes”....Pages 167-167
Total Pharyngolaryngoesophagectomy for Hypopharyngeal, Laryngeal, and Cervical Esophageal Carcinoma....Pages 200-202
Reconstruction with Free Jejunal Autograft for Cervical Esophageal Stenosis....Pages 203-205
Front Matter....Pages 206-208
Evaluation of E-Cadherins in Growth Patterns of Gastric Cancer and Its Degree of Cell Differentiation....Pages 209-209
Ornithine Decarboxylase Activity in Human Stomach Cancer....Pages 210-211
Significance of Helicobacter Pylori in Gastrocarcinogenesis: Special Reference to Tissue IgA Antibody in Chronic Gastritis and Intestinal Metaplasia....Pages 212-214
Risk of Cancer Development in the Gastric Remnant by B-II Resection....Pages 215-217
Study on Cancer of the Gastric Remnant by the Type of Reconstruction at Previous Gastrectomy....Pages 218-220
Tumor Markers (AFP, CEA, CA19-9, CA125) for Detecting Recurrence of Gastric Cancer....Pages 221-223
Non-Anatomical Prognostic Factors for Gastric Cancer Patients: Significance of Tumor Markers....Pages 224-226
Gastric Acid Secretion and Serum Gastrin Levels in Gastric Cancer....Pages 227-229
Early Detection of α-Fetoprotein Producing Gastric Cancer by Reverse Transcriptase-Polymerase Chain Reaction....Pages 230-232
Preoperative Prediction of Gastric Cancer Extension by in Vitro Labelling Index of Bromodeoxyuridine....Pages 233-235
Immunohistochemical Study of PCNA (Proliferating Cell Nuclear Antigen) in Gastric Cancer with Special Reference to Progression and Prognosis....Pages 236-238
c-myc Gene Expression in Primary Gastric Cancer....Pages 239-241
Expression of CD44 Molecule in Gastric Cancer....Pages 242-244
Sialyl-Tn Antigen as a Predictor of Survival Time for Patients with Gastric Carcinoma....Pages 245-247
Expression of Sialosyl Tn Antigen in Gastric Cancer....Pages 248-250
Immunohistochemical Evaluation of α-Catenin, Cadherin-Associated Intercellular Protein, Expression in Human Gastric Cancer....Pages 251-253
Expression of Tenascin in Gastric Cancers and Their Clinicopathological Features....Pages 254-256
Front Matter....Pages 257-259
Study of a Synthesized New Carbohydrate Antigen in Gastro-Intestinal Cancers....Pages 209-209
Histochemical Study of the Extra-Cellular Stroma in Gastric Cancer....Pages 260-262
The Value of Microvessels in the Tumor of Gastric Carcinoma....Pages 263-265
Diagnosis of Lymph Nodes with Metastasis from Stomach Cancer Using Ultrasonography....Pages 266-268
Prognostic Factors for Gastric Cancer Patients — Alternation of the Significance in 6,540 Patients Treated Over a 30-Year Period....Pages 269-271
Clinicopathological Characteristics of Cases with Metastasis to Lower Mediastinal Lymph Nodes and Treatment in Gastric Cancer with Esophageal Invasion....Pages 272-274
Surgical Approach for Gastric Cancer Extended to the Esophagus....Pages 275-276
A New Surgical Approach for Resection of Cancer of Gastric Cardia....Pages 277-279
A Study on the Status of Lymph Node Motastasis in Cancer of the Upper Third Stomach....Pages 280-282
Role of MMC-Adsorbed Activated Carbon (MMC-CH 40 ) in Guiding Resection of the Lymph Nodes in Patients with Gastric Cancer....Pages 283-285
MMC-CH 40 Staining the Regional Lymphnodes in the Use of Radical Operation for Gastric Cancer....Pages 286-288
The Evaluation of Intraoperative Injection of Microcarbon Particles to Extended Lymph Nodes Dissection for Gastric Cancer....Pages 289-291
Is It Correct Whether Pancreato-Splenectomy Is Essential for Dissection and Removal of Lymph Nodes Along the Splenic Artery?....Pages 292-293
Evaluation of Super Extensive Lymph Node Dissection (R4) for Advanced Gastric Cancer....Pages 294-296
Metastasis to Minute Lymph Node in Gastric Cancer, Its Significance for Indication of Endoscopic or Local Surgical Treatments....Pages 297-299
Roux-en-Y End-to-Side Esophagojejunostomy with Stapler After Total Gastrectomy....Pages 300-302
The Role of Absolute Noncurative Gastrectomy for Primary Gastric Cancer....Pages 303-305
Proper Indication of Gastrectomy for the Gastric Carcinomas with Liver Metastasis....Pages 306-308
Gastric Cancer Developing 40 Years after Simple Gastrojejunostomy....Pages 309-311
A Rare Case of Huge Gastric Carcinoma with Extramural Growth....Pages 312-314
Front Matter....Pages 315-317
Multidisciplinary Treatment of Gastric Endocrine Cell Carcinoma and Large Liver Metastasis....Pages 209-209
Limited Surgery for the Early Gastric Cancer....Pages 318-320
Pylorus Preserving Gastrectomy (PPG) with Lymph Node Dissection for Early Gastric Cancer in the Middle Third of the Stomach....Pages 321-323
Pylorus-Preserving Gastrectomy for Gastric Cancer....Pages 324-326
Indication and Postoperative Evaluation of Pylorus Preserving Gastrectomy for Early Gastric Cancer....Pages 327-329
Gallbladder Function After Pylorus Preserving Gastrectomy for Gastric Cancer....Pages 330-332
Adverse Effects of Regurgitant Duodenal Content on the Mucosa of the Residual Stomach After Partial Gastrectomy....Pages 333-335
Early Stomach Cancer in Turkey....Pages 336-338
Multiple Early Cancer of the Stomach....Pages 339-341
Are There Any Pathologic Differences Between Mucosal and Submucosal Cancer of the Stomach?....Pages 342-344
Recurrence of Early Gastric Cancer....Pages 345-347
A Study of Rational Dissection of Regional Lymph Node in Early Gastric Cancer....Pages 348-350
Study of Distribution of Minute Gastric Cancerous Foci in Multiple Early Gastric Cancer Cases — In Order to Decide the Extent of Gastric Resection....Pages 351-353
Indication for Curative Endoscopic Mucosal Resection for Early Gastric Cancer: Analysis of 290 Surgical Cases....Pages 354-356
Lymph Node — Targeting Delivery of Adriamycin by Liposomal Administration into Gastric Submucosa in Rabbits....Pages 357-359
Anti-Cancer Effects of Preoperative Chemotherapy for Gastric Carcinoma — The Relationship Between Histopathological Effects and Thymidilate Synthetase Inhibition Rate (TSIR)....Pages 360-362
Neoadjuvant Chemotherapy for Far Advanced Scirrhous Carcinoma (Linitis Plastica) of the Stomach and Its Significance....Pages 363-365
Neoadjuvant Chemotherapy (UFT· CDDP Therapy) for Borrmann 4 Type Gastric Carcinoma....Pages 366-368
Effects of Neoadjuvant Chemotherapy on High-Grade Advanced Gastric Cancers....Pages 369-371
Pharmacological Study of Continuously Infused Tegafur or 5-Fluorouracil in Treatments of Patients with Gastric Adenocarcinoma....Pages 372-374
Front Matter....Pages 375-376
Adhesive Tumor Cell Culture System (ATCCS) — Chemosensitivity Assay in Gastric Cancer with Emphasis on the Possibility of Preoperative Analysis by Data of Gastrobiopsy....Pages 209-209
Effects of Surgical Adjuvant Chemotherapy and Combined Resection of Adjacent Organs on the Survival Rate of Gastric Cancer Patients....Pages 377-379
Evaluation of Combination Chemotherapy Using 5-FU, Leucovorin, and CDDP (FLP Therapy) Against Recurrent or Advanced Stomach Cancer....Pages 380-382
Local Immunotherapy for Gastric Cancer Using a Mixture of OK-432 and Fibrinogen....Pages 383-385
Intralymph Nodal Injection of The Mixture of OK-432 and Mitomycin C (MMC) Adsorbed onto Fine Activated Carbon Particles (CH 40 ) for the Treatment of Lymph Node Metastasis....Pages 386-387
Clinical and Immunological Effects of Locoregional Immunochemotherapy for Either Liver Metastases or Peritoneal Dissemination of Gastric Cancer....Pages 388-390
Suppression of Cytokines Production in Peripheral and Regional Lymph Node Lymphocytes from Patients with Gastric Cancer and the Augmentative Effect of BRM....Pages 391-393
Effect of Splenectomy on Prognosis in Immunochemotherapy After Total Gastrectomy for Gastric Cancer....Pages 394-396
Immunosuppressive Acidic Protein and Postoperative Immunotherapy in Gastric Cancer....Pages 397-399
Prevention of Growth of a Human Gastric Cancer Xenograft in Nude Mice with Anti-EGF Receptor Antibody....Pages 400-402
Intraperitoneal Administration of Recombinant Interleukin-2 (rIL-2) Against Peritoneal Dissemination of Gastric Cancer....Pages 403-405
The Prognostic Effect of the Immuno-Chemotherapy to Gastric Cancer with Peritoneal Metastasis....Pages 406-408
Continuous Hyperthermic and Normothermic Peritoneal Perfusion for the Prevention of Peritoneal Recurrence of Gastric Cancer — A Randomized Control Study....Pages 409-411
Front Matter....Pages 412-414
Establishment of Human Gastric Cancer Cell Line (SGC-7901) Intraperitoneally Transplantable in Nude Mice....Pages 415-415
Effect of Laminin Receptor Ligands on Peritoneal Metastasis....Pages 416-418
Adjuvant Intraperitoneal High-Dose Chemotherpay with Mitomycin C in Patients with Primary Advanced Gastric Cancer....Pages 419-421
The Effects of Intraperitoneal Administration with High-Dose MMC and OK-432 Against Far Advanced Gastric Cancer....Pages 422-424
Intraperitoneal Administration of Cisplatin for Patients with Gastric Cancer and Peritoneal Dissemination....Pages 425-427
Intraperitoneal Cisplatin Microspheres for the Management of Malignant Ascites....Pages 428-430
Front Matter....Pages 431-433
Role of Dye Endoscopy with Lugol in the Diagnosis of Esophageal Carcinoma....Pages 435-435
Front Matter....Pages 436-438
Endoscopic Examination for the Early Esophageal Cancer in Patients with Head and Neck Cancers....Pages 435-435
Effect of Routine Endoscopy on Critical Assessment in Diagnosis of Intestinal Metaplasia at Mexico General Hospital....Pages 439-441
Management of Early Colorectal Carcinoma Defined by Endoscopic Findings....Pages 442-443
Intraportal Endovascular Ultrasonography for Pancreatobiliary Carcinoma....Pages 444-446
New Endoscopic Mucosectomy Technique for Early Cancer of Esophagus, Stomach, and Colon....Pages 447-448
Endoscopic Mucosal Resection of Early-Stage Esophageal Cancer....Pages 449-451
The Elevated Type Early Gastric Cancer as the Subject of the Endoscopic Resection or the Conservative Surgical Operation....Pages 452-454
Endoscopic Surgery for Early Gastric Cancer and the Points Which Demand Special Attention....Pages 455-457
Endoscopic Treatment of Early Gastric Cancer and Evaluation of Submucosography in the Diagnosis of the Depth of Cancer Invasion....Pages 458-460
Endoscopic Treatment for the Cancer and Submucosal Tumor of the Upper Gastrointestinal Tract....Pages 461-463
Front Matter....Pages 464-466
Characteristics of Cancer of the Large Bowel and Implication of Intestinal Flora and Bile Acids as Causal Factors....Pages 467-467
Effect of Apple Pectin on Azoxymethane-Induced Colon Carcinogenesis — Fecal Enzyme Activities and Prostaglandin E2 Level in Colonic Mucosa....Pages 468-470
Inhibitory Effect of Green Tea Extract Against Azoxymethane-Induced Colon Carcinogenesis in Rat....Pages 471-473
Significance of Fecal Bile Acid Ratio in Colorectal Cancer Patients....Pages 474-476
Effect of Short Chain Fatty Acids on Histopathological Type of Colon Cancer Induced by 1,2-Dimethylhydrazine in Rat....Pages 477-478
Relationship Between Gastrin Receptor Values in Colorectal Cancer Tissues and Clinical Stage....Pages 479-481
DNA Index and p53 Immunoreaction in Colorectal Cancer and Its Relationship to Prognosis....Pages 482-483
Relationship Between Fecal Mutant p53 Protein and Colorectal Cancers....Pages 484-486
Proliferating Cell Nuclear Antigen Expression in Colorectal Cancer According to the Depth of Invasion....Pages 487-489
The Expression of Neural Cell Adhesion Molecule in Advanced Rectal Cancer....Pages 490-492
Front Matter....Pages 493-495
Laparoscopic-Assisted Partial Colectomy for Early Colon Carcinoma....Pages 467-467
Local Recurrence After Local Excision of Early Rectal Cancer....Pages 538-540
Management Of Colorectal Cancer....Pages 541-543
Surgical Trial for Rectal Cancer Using a Tissue Expander in Association with Pelvic Partition to Prevent Radiation-Induced Bladder Dysfunction....Pages 544-546
A Novel Method for Restoration of Postoperative Defecation Function in the Patients with the Lower Rectal Cancer....Pages 547-548
Prognosis of Colorectal Cancer Related to Histopathological Type and Stage....Pages 549-551
A Clinicopathological Study of Surgically Treated Colorectal Cancer....Pages 520-522
Prognostic Features of Colorectal Cancer in the Young Adult....Pages 523-525
Surgical Treatment for Juvenile Colorectal Carcinoma (Below the Age of 40)....Pages 526-528
Early Invasive Colorectal Carcinoma — A Retrospective Study About Risk Factors of Nodal Metastasis....Pages 529-531
Perioperative Blood Transfusion Adversely Affects Prognosis of Colorectal Cancer Patients....Pages 532-534
Patterns of Recurrence in Rectal Carcinoma Following Curative Resection: What Did the Post-Operative Radiotherapy Do?....Pages 535-537
Diagnostic Significance of Serum CEA and CA19-9 Levels in Colorectal Cancers....Pages 552-554
Evaluation of Preoperative Serum CEA and IAP Levels in the Patients with Colorectal Cancer....Pages 502-504
The Meanings of CEA in Gallbladder Bile in Colorectal Cancer....Pages 505-507
The Relationship Between Metastatic Potential and the Expression of Sialyl Lewis A (CA 19–9) and Sialyl Lewis X Antigens in Colorectal Cancer....Pages 508-510
Laminin Levels and Stage of Vascular Invasion as Predictive Factors of Liver Metastasis in Colon Cancer....Pages 511-513
Elevated Serum Levels of Soluble Tumor Necrosis Factor Receptors in Patients with Colorectal Cancer....Pages 514-516
Sialyl Lewis-X Antigen Expression in Human Colorectal Carcinomas: Relationship Between Expression Level and Prognosis....Pages 517-519
A Scanning Electron Microscope Study of the Fibrous Stroma Adjacent to the Tumor Acini of Invasive Colonic Cancers....Pages 496-498
Front Matter....Pages 499-501
The Role of Lateral Lymphnode Dissection in the Prevention of Recurrence for Rectal Cancer....Pages 467-467
Indications of Operative Modalities and Analysis of Local Recurrence after Curative Surgery for Rectal Cancer....Pages 555-557
Cryosurgical Treatment For Local Recurrence Of Rectal Cancer....Pages 558-560
An Application of 201T1-SPECT for Evaluating in Carcinoma of Digestive Diseases (Thallium-Technetium Subtraction SPECT of Hepatobiliary Carcinoma)....Pages 561-563
Radioimmunoimaging of Local Recurrence of Rectal Cancer by Radiolabeled Mouse Monoclonal Antibody A7....Pages 564-566
Investigation of Thymidylate Synthase Induction in Colorectal Carcinoma Tissues After Administration of Anticancer Drug, Fluorinated Pyrimidine Fluoride Derivatives....Pages 567-569
Effect and Action Mechanism of Prostaglandin E2 on Proliferation of Human Colon Cancer Cells in Culture....Pages 570-572
Combination Therapy with CPT-11 and Interferon-α Against Human Colon Carcinoma in Nude Mice....Pages 573-575
Expressions of HLA and Adhesion Molecules in Colorectal Cancer and the Effects of Local Administration of Interferon (IFN) Gamma and OK-432....Pages 576-578
A New Chemotherapy to Reduce The Local Recurrence of Rectal Cancer....Pages 579-581
Preoperative 60 Co High Dose Rate Intraluminal Radiotherapy for Advanced Lower Rectal Cancer....Pages 582-584
Histopathological Assessment in Rectal Carcinoma with Preoperative High-Dose-Rate Intraluminal Brachytherapy....Pages 585-587
Development of a Cisplatin Suppository for Regional Chemotherapy of Ano-Rectal Cancer....Pages 588-590
Radiological Findings of Minute and Small Depressed Colorectal Neoplasm....Pages 591-593
Front Matter....Pages 594-596
Comparative Epidemiology of Liver Cirrhosis and Liver Cancer in Japan....Pages 597-597
Prevalence of Hepatitis B, C and Delta Viral Markers in Turkish Patients with Hepatocellular Carcinoma....Pages 598-600
Glutaminase and Glutamine Synthetase Activities During Azo-Dye Hepatocarcinogenesis in Rat....Pages 601-603
Expression of the Antimetastatic Gene nm23 in Human Hepatocellular Carcinomas....Pages 604-606
Decreased Frequency of Mitochondrial DNA Deletion in Hepatoma Developed from Cirrhotic Liver Detected by PCR Method....Pages 607-609
The Significance of Biological Factors (DNA Ploidy Pattern, AgNOR Scores and Various Tumor Markers) in Cholangiocellular Carcinoma....Pages 610-612
Front Matter....Pages 613-615
Diagnosis of Small Hepatocellular Carcinoma: Significance of Ultrasound and Tumor Markers....Pages 597-597
Evaluation of Ultrasonically Guided Liver Biopsy for the Diagnosis of Small Hepatocellular Carcinoma....Pages 616-618
The Significance of the Determination of AFP-Isoform in the Early Diagnosis of Hepatocellular Carcinoma (HCC)....Pages 619-621
Intratumor Pressure in Hepatocellular Carcinoma....Pages 622-624
Evaluation of Multislice Dynamic MRI of the Whole Liver by Turbo-FLASH Method....Pages 625-627
Non-Invasive Quantification of Human Liver Neoplasms by Positron Emission Tomography(PET) Using C 15 O 2 Steady State Method....Pages 628-630
Short-Term Results of Resection for Hepatocellular Carcinoma: A New Preoperative Combination Therapy....Pages 631-633
Factors Affecting Long-Term Survival and Recurrence of Hepatocellular Carcinoma (HCC) After Hepatic Resection....Pages 634-636
Indication Criteria of Hepatectomy for Hepatocellular Carcinoma Based on Long-Term Result....Pages 637-639
Results of Hepatic Resection for Small Liver Cancer....Pages 640-642
Adverse Relationship Between Blood Transfusion and Survival After Hepatectomy for Hepatocellular Carcinoma Using Microtaze....Pages 643-644
Biliary Obstruction Due to Hepatocellular Carcinoma (HCC) — Report of Six Cases....Pages 645-647
Comparison Between Portal Vein Branch Ligation and Embolization for Compensatory Hyperplasia of Unoccluded Hepatic Lobe....Pages 648-650
Preoperative Portal Vein Embolization for Hepatocellular Carcinoma with Portal Thrombi....Pages 651-653
Therapeutic Strategy for Advanced Hepatocellular Carcinoma Using Systemic Interleukin-2 Infusion and Local Low-Dose Irradiation....Pages 654-656
Fundamental Studies on Direct Injection of Ethanol (Et)+Polyethylene Glycol (PEG) Mixture into Hepatocellular Carcinoma (HCC) in Rats....Pages 657-659
Segmental/Subsegmental Hepatic Arterial Embolization — A New Therapy for Hepatocellular Carcinoma....Pages 660-662
Factors Involved in the Resistance to Repeated Transcatheter Arterial Embolization for Hepatocellular Carcinoma....Pages 663-665
A New Approach to the Treatment of Hepatocellular Carcinoma with Intrahepatic Metastases — Transarterial Immuno-Embolization (TIE) with OK-432 and Fibrinogen....Pages 666-668
Effect of Intra-Arterial Injection of Mitoxantrone-Lipiodol Emulsion on Hepatocellular Carcinoma....Pages 669-671
Front Matter....Pages 672-674
Treatment of Unresectable Hepatocellular Carcinoma by Intra-Arterial Infusion of THP-Adriamycin Under Occlusion of Hepatic Arterial Flow....Pages 597-597
Combination of Hepatic Arterial Infusion Chemotherapy and Portal Vein Occlusion for Unresectable Hepatocellular Carcinoma....Pages 675-677
Tumor Marker Doubling Time of Liver Metastases from Stomach and Colonic Cancer and Its Clinical Significance....Pages 678-680
Prognosis of Liver Metastases from Colorectal Cancer After Hepatectomy....Pages 681-683
Hepatic Metastasectomy of Colorectal Cancer: Evaluation of 8 Years Result....Pages 684-686
Extensive Surgery for Carcinoma Recurrence After Initial Hepatectomy for Liver Metastasis of Colorectal Carcinoma....Pages 687-689
Prognostic Comparison of Hepatic Resection of Liver Metastases and Chemotherapy via the Portal Vein with Liposome-Entrapped Adriamycin for Unresectable Liver Metastases on Gastric Cancer....Pages 690-692
Management of Metastatic Liver Cancer....Pages 693-695
A Study of Prophylactic Arterial Infusion Chemotherapy for Remnant Liver in Case of Resected Liver Metastasis from Colorectal Cancer....Pages 696-698
Hepatic Arterial Infusion Therapy with Leucovorin 5-Fluorouracil for Liver Metastasis of Gastric Colorectal Cancer....Pages 699-701
The Therapeutic Effects of Liposomal Adriamycin Pretreated with Lentinan....Pages 702-704
Continuous Hepatic or Splenic Arterial Infusion of Recombinant Interleukin-2 (rIL-2) and Cyclophosphamide(CY) in Patients with Liver Metastasis of Colorectal Carcinoma and Hepatobiliary Carcinoma....Pages 705-707
Effects of Serial Transarterial Infusion Chemotherapy Combination with Multi-BRM for Metastatic Liver Tumor....Pages 708-710
A Simple New Method of Hyperthermo-Chemo-Hypoxic Isolated Liver Perfusion for Hepatic Metastasis....Pages 711-713
Prophylactic Effects of Doxorubicin on Hepatic Recurrence of Colonic VX2 Cancer Lesions....Pages 714-716
Effect of OK-432 for Prevention of Spontaneous Metastasis in the Liver....Pages 717-719
Effects of Continuous Venous or Portal Administration of Carboplatin Against VX 2 Tumor Metastasizing to the Liver....Pages 720-722
Experimental Study on the Efficacy of Intrahepatic Arterial and Portal Venous Infusion of Anticancer Drugs to Inhibit the Growth of Portally Inoculated VX-2 Carcinoma....Pages 723-725
Anti-Angiogenic Agent, AGM-1470 Inhibited Liver Metastasis of VX2 Carcinoma in Rabbits....Pages 726-728
Anticancer Effects of an Angiogenesis Inhibitor (TNP-470) After Arterial Injection in Rabbits Bearing VX-2 Carcinoma....Pages 729-731
Front Matter....Pages 732-734
Liposomes Coated with Molecular Recognition Site Are Useful for Active Targeting Chemotherapy on Cancer Cells....Pages 597-597
Augmentation of Uptake of Mitomycin C in the Tumor Tissue After Infusion of Plasma Treated with Protein A: A Model Study of Metastatic Liver Tumor Using Rabbits Bearing Vx2 Carcinoma....Pages 735-736
Metastases Models of Human Colon Cancer in Congenitally Athymic Mice....Pages 737-739
Adhesion of Human Cancer Cells to Vascular Endothelium Mediated by a Carbohydrate Antigen, SPan-1....Pages 740-742
Front Matter....Pages 743-745
Extended Pancreatectomy for Locally Advanced Pancreatic Cancer Involving the Portal Vein — Indications and Limitations....Pages 747-747
Indications for Extended Radical Whipple Operation for Ductal Adenocarcinoma of the Head of the Pancreas....Pages 748-750
Simultaneous Intraoperative Interstitial Hyperthermia and Intraoperative Electron Beam Radiation Therapy for Pancreatic Carcinoma....Pages 751-752
Resection of Remote Metastases from Pancreatic Cancer in Patients Previously Treated with Radical Resection Combined with Intraoperative Radiation Therapy....Pages 753-755
A Quantitative Analysis of Gastrointestinal Motility After Intraoperative High Dose Irradiation to Paraaortic Lymph Nodes in Dogs....Pages 756-758
Immunohistological Expression of Pancreatic Cancer Associated Mucin Antigen and Radioimmunodetection in Pancreatic Cancer....Pages 759-761
Biodistribution and Imaging of Chimeric Fab Fragment of Anti-Carcinoembryonic Antigen (CEA) Monoclonal Antibody in Nude Mice Bearing Pancreatic Carcinoma Xenografts....Pages 762-764
Biodistribution of Monoclonal Antibody Nd2 Following Administration of Several Routes....Pages 765-767
Enhanced Antitumor Effect of Neocarzinostatin Conjugated to Monoclonal Antibody A7 on Human Pancreatic Carcinoma Grafted in Nude Mice....Pages 768-770
TNF-α, IFN-α and Tegafur Combination Therapy for Advanced Pancreatic Cancer....Pages 771-773
Differential Diagnosis of the Cystic Lesion of the Pancreas....Pages 774-776
Adjuvant Therapy Following Resection of Pancreatic Head Carcinoma According to the Histopathological and Biological Features....Pages 777-778
Nuclear DNA Content and Short-Term Survival Analysis in Carcinoma of the Pancreas: A Study Using Flow Cytometry....Pages 779-781
Long Term Prognosis and DNA Ploidy Pattern After Pancreatoduodenectomy for Cancer of the Head of the Pancreas....Pages 782-784
Role of O-Linked Oligosaccharides and Sialic Acids in Pancreatic Cancer Cell Interaction with Extracellular Matrix....Pages 785-787
Front Matter....Pages 788-790
UICC and Japanese Stage Classifications for Carcinoma of the Gallbladder....Pages 791-791
Front Matter....Pages 792-794
Clinicopathologic Factors Influencing Survival of the Patients with Bile Duct Carcinoma: A Multivariate Statistical Analysis....Pages 791-791
Gallbladder Cancer Associated with Anomalous Junction of the Pancreaticobiliary Ductal System Without Bile Duct Dilatation....Pages 795-797
Detection and Surgical Treatment of Gallbladder Cancer Operated for Cholelithiasis....Pages 798-800
Resection with Preoperative Radiation Therapy for Cancer of the Extrahepatic Bile Duct....Pages 801-803
Radiation Therapy in the Treatment of Bile Duct Cancer....Pages 804-806
Differentiation Therapy for Human Bile Duct Cancer....Pages 807-809
Front Matter....Pages 810-812
Significance of Membrane Lymphotoxin (mLT) Expressed on Killer Cells for Adoptive Immunotherapy....Pages 813-813
The Generation of CD4 Cytotoxic T Lymphocyte Augmented by Immobilized Anti-CD3 Antibody and Interleukin-2....Pages 814-816
HLA-DR Expression on Cancer Cells and T Cell Reaction in Colorectal Carcinoma....Pages 817-819
Therapeutic Efficacy of a Tumor-Infiltrating Lymphocyte Clone in Combination with Soluble Tumor-Specific Transplantation Antigen and Cyclophosphamide....Pages 820-822
Enhancement of Tumor Cell Susceptibility to Tumor-Infiltrating Lymphocyte by Treatment with Cisplatin....Pages 823-825
Changes of Lymphocyte Subsets Following Various Surgical Stress....Pages 826-828
Front Matter....Pages 829-831
Chemotherapy Induced Toxicity and Its Relation with Tissue DNA Synthesis: A Circadian Stage Dependent Study....Pages 833-833
Leukopenia Due to 5-Fluorouracil (5-FU) Administration Is Improved by Glutamine Supplemented Elemental Diet (Gln-ED)....Pages 834-836
Gianturco-Rosch Expandable Metallic Biliary Stent Applied for Treatment of Biliary Strictures....Pages 837-839
Statistical Reappraisal of Cancer Staging System....Pages 840-842
Study on the Central Mechanism of Indomethacin for Relieving GI Cancer Pain....Pages 843-845
Effects of TPN or Enteral Nutrition on Gallbladder Motor Function in Postoperative Gastric Cancer Patients....Pages 846-848
Surgical Management of Digestive Cancers in Chronic Hemodialysis Patients....Pages 849-851
Back Matter....Pages 852-854
....Pages 855-867